Role of Ammonia and Inflammation in Minimal Hepatic Encephalopathy

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2007 Jan 30

PMID 17260161

Citations 107

Authors

D L Shawcross

G Wright

S W M Olde Damink

R Jalan

Affiliations

Soon will be listed here.

Abstract

Background: Minimal hepatic encephalopathy (MHE) is common in cirrhosis but its pathophysiologic basis remains undefined. We evaluated whether the presence of MHE was associated with severity of liver disease, ammonia levels or the presence of inflammation and assessed factors determining neuropsychological deterioration accompanying induction of hyperammonemia.

Methods: Eighty four cirrhotics were studied. A neuropsychological test battery was performed and blood taken for ammonia, WCC, CRP, nitrate/nitrite, IL-6 and amino acids, before and after, induction of hyperammonemia by administration of a solution mimicking the amino acid composition of haemoglobin (60) or placebo (24).

Results: The presence and severity of MHE were independent of severity of liver disease and ammonia concentration but markers of inflammation were significantly higher in those with MHE compared with those without. Induction of hyperammonemia produced deterioration in one or more neuropsychological tests by > or =1 SD in 73.3%. This was independent of the magnitude of change in plasma ammonia and severity of liver disease but was significantly greater in those with more marked inflammation.

Conclusion: Our data show that inflammation is an important determinant of the presence and severity of MHE. The change in neuropsychological function following induced hyperammonemia is greater in those with more severe inflammation.

Citing Articles

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.

Devasia A, Ramasamy A, Leo C Int J Mol Sci. 2025; 26(4).

PMID: 40004240 PMC: 11855529. DOI: 10.3390/ijms26041778.

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis.

Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I Nutrients. 2025; 17(2.

PMID: 39861356 PMC: 11768058. DOI: 10.3390/nu17020226.

Contribution of extracellular vesicles to neuroinflammation and cognitive and motor deficits in hyperammonemia and hepatic encephalopathy.

Izquierdo-Altarejos P, Felipo V Extracell Vesicles Circ Nucl Acids. 2024; 5(1):37-43.

PMID: 39698415 PMC: 11648396. DOI: 10.20517/evcna.2023.66.

Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertion.

Tiede A, Stockhoff L, Ehrenbauer A, Rieland H, Cornberg M, Meyer B Metab Brain Dis. 2024; 40(1):58.

PMID: 39656322 PMC: 11632008. DOI: 10.1007/s11011-024-01436-2.

Extracellular Vesicles from Mesenchymal Stem Cells Reverse Neuroinflammation and Restore Motor Coordination in Hyperammonemic Rats.

Izquierdo-Altarejos P, Martinez-Garcia M, Atienza-Perez I, Hernandez A, Moreno-Manzano V, Llansola M J Neuroimmune Pharmacol. 2024; 19(1):52.

PMID: 39382610 DOI: 10.1007/s11481-024-10153-7.

References

Licinio J, Wong M . Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest. 1998; 100(12):2941-7. PMC: 508504. DOI: 10.1172/JCI119846. View

Groeneweg M, Quero J, de Bruijn I, Hartmann I, Essink-Bot M, Hop W . Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998; 28(1):45-9. DOI: 10.1002/hep.510280108. View

Amodio P, Montagnese S, Gatta A, Morgan M . Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004; 19(3-4):253-67. DOI: 10.1023/b:mebr.0000043975.01841.de. View

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A . Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002; 35(3):716-21. DOI: 10.1053/jhep.2002.31250. View

Lockwood A . Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis. 2004; 19(3-4):345-9. DOI: 10.1023/b:mebr.0000043980.74574.eb. View

Frith C, Leary J, Cahill C, Johnstone E . Performance on psychological tests. Demographic and clinical correlates of the results of these tests. Br J Psychiatry Suppl. 1991; (13):26-9, 44-6. View

Liu Q, Duan Z, Ha D, Bengmark S, Kurtovic J, Riordan S . Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004; 39(5):1441-9. DOI: 10.1002/hep.20194. View

Shawcross D, Balata S, Olde Damink S, Hayes P, Wardlaw J, Marshall I . Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol. 2004; 287(3):G503-9. DOI: 10.1152/ajpgi.00104.2004. View

Hindmarch I . Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980; 10(3):189-209. PMC: 1430071. DOI: 10.1111/j.1365-2125.1980.tb01745.x. View

10.

Amodio P, Marchetti P, Del Piccolo F, Campo G, Rizzo C, Iemmolo R . Visual attention in cirrhotic patients: a study on covert visual attention orienting. Hepatology. 1998; 27(6):1517-23. DOI: 10.1002/hep.510270608. View

11.

Balata S, Olde Damink S, Ferguson K, Marshall I, Hayes P, Deutz N . Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology. 2003; 37(4):931-9. DOI: 10.1053/jhep.2003.50156. View

12.

Wan W, Wetmore L, Sorensen C, Greenberg A, Nance D . Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull. 1994; 34(1):7-14. DOI: 10.1016/0361-9230(94)90179-1. View

13.

Vaquero J, Chung C, Cahill M, Blei A . Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis. 2003; 23(3):259-69. DOI: 10.1055/s-2003-42644. View

14.

OCarroll R, MacLeod D . Moderate altitude has no effect on choice reaction time in international rugby players. Br J Sports Med. 1997; 31(2):151-2. PMC: 1332619. DOI: 10.1136/bjsm.31.2.151. View

15.

Gorg B, Foster N, Reinehr R, Bidmon H, Hongen A, Haussinger D . Benzodiazepine-induced protein tyrosine nitration in rat astrocytes. Hepatology. 2003; 37(2):334-42. DOI: 10.1053/jhep.2003.50061. View

16.

Shawcross D, Davies N, Williams R, Jalan R . Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004; 40(2):247-54. DOI: 10.1016/j.jhep.2003.10.016. View

17.

Weissenborn K, Ennen J, Schomerus H, Ruckert N, Hecker H . Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001; 34(5):768-73. DOI: 10.1016/s0168-8278(01)00026-5. View

18.

Douglass A, Al Mardini H, Record C . Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. J Hepatol. 2001; 34(5):658-64. DOI: 10.1016/s0168-8278(01)00004-6. View

19.

Rees C, Oppong K, Al Mardini H, Hudson M, Record C . Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut. 2000; 47(4):571-4. PMC: 1728090. DOI: 10.1136/gut.47.4.571. View

20.

Davies A . The influence of age on trail making test performance. J Clin Psychol. 1968; 24(1):96-8. DOI: 10.1002/1097-4679(196801)24:1<96::aid-jclp2270240131>3.0.co;2-u. View